Cargando…
HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy
Cell cycle progression and DNA synthesis are essential steps in cancer cell growth. Thymidylate synthase (TS) is a therapeutic target for 5FU. We tested the hypothesis that HSP90 transcriptional and functional inhibition can inhibit cell cycle progression, downregulate TS levels and sensitize colore...
Autores principales: | Nagaraju, Ganji Purnachandra, Alese, Olatunji B., Landry, Jerome, Diaz, Roberto, El-Rayes, Bassel F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259452/ https://www.ncbi.nlm.nih.gov/pubmed/25296971 |
Ejemplares similares
-
MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
por: Matuszyk, Janusz
Publicado: (2022) -
Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer
por: Ahn, Ji-Young, et al.
Publicado: (2015) -
Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma
por: Wong, N A C S, et al.
Publicado: (2001) -
Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study
por: Prieto, Veronica, et al.
Publicado: (2017) -
Effect of Hammerhead Ribozyme against Human Thymidylate Synthase on the Cytotoxicity of Thymidylate Synthase Inhibitors
por: Kobayashi, Hiroyuki, et al.
Publicado: (1995)